Folic Acid Intervention During Recovery
Effect of Preoperative Folic Acid Intervention on Postoperative Recovery Period in Children With Head and Neck and Maxillofacial Surgery
1 other identifier
interventional
300
0 countries
N/A
Brief Summary
Research purposes:Comparison of preoperative folic acid and placebo intervention on postoperative recovery of sputum in children undergoing general anesthesia for head and neck and maxillofacial surgery Test type:Randomized, double-blind, placebo-controlled, prospective study Randomized grouping: Patients were randomized into an intervention group (fed for 7 days before surgery) and a placebo group (7 days for placebo) Test subjects: recruitment and sample size calculation, inclusion criteria, exclusion criteria, shedding cases, trial suspension, rejection criteria, trial termination,Test contents Evaluation indicators: main observation indicators, secondary observation indicators Adverse events: definition of adverse events, recording of adverse events, treatment of adverse events, assessment of adverse events, serious adverse events, definition of serious adverse events, recording and reporting of serious adverse events
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2019
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 21, 2019
CompletedFirst Posted
Study publicly available on registry
October 23, 2019
CompletedStudy Start
First participant enrolled
December 30, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2021
CompletedOctober 25, 2019
October 1, 2019
2 years
October 21, 2019
October 23, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The incidence of sputum in children
The incidence of sputum in children with major indicators was tested by chi-square test or exact probability method.
8 days
Study Arms (2)
Intervention group
EXPERIMENTALIntervention group: patients took 7 days of folic acid tablets before surgery (0.3mg/d for children aged 1-3, 0.4mg/d for children aged 4\~5 years, dissolved in 20ml brown sugar water.)
Placebo group
EXPERIMENTALPlacebo group: The patient received the same dose of brown sugar water for 7 days before surgery. Folic acid dose selection is based on the maximum daily intake of children(tolerable upper intake levels,UL)
Interventions
The patient was continuously taking 7 ml of a brown sugar aqueous solution containing a certain amount of folic acid for 7 days before surgery (0.3 mg/d for children with 1-3 years old and 0.4 mg/d for children aged 4 to 5, once a day). After the operation, the PAED scores were performed every 10 minutes during the recovery of the child, at the time of extubation, and within 30 minutes after extubation. The PAED scores of all the children were performed by the same measurer. (The total score is 0\~20 points, and the score ≥10 points is defined as the recovery period).
Patients in the placebo group received 20 ml of an aqueous solution of brown sugar with the same concentration as the intervention group on the 7th day before surgery. After the operation, the PAED scores were performed every 10 minutes during the recovery of the child, at the time of extubation, and within 30 minutes after extubation. The PAED scores of all the children were performed by the same measurer. (The total score is 0\~20 points, and the score ≥10 points is defined as the recovery period).
Eligibility Criteria
You may qualify if:
- ASA is graded from I to II
- Children between the ages of 1 and 5
- The weight is greater than or equal to 8.5kg
- It is planned to undergo head and neck and maxillofacial surgery under general anesthesia
You may not qualify if:
- Children with a history of respiratory infection within 1 week
- Children with congenital malformations such as congenital heart disease
- Children with central nervous system diseases or those with mental disorders or mental disorders
- Children with long-term use of sedative or analgesic drugs
- Children with severe liver and kidney dysfunction
- receiving folic acid supplementation therapy or taking related derivatives
- Taking drugs that affect absorption in the past 1 month, such as sulfonamides, aspirin, etc.
- Participated in other related clinical studies in the past 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Sikich N, Lerman J. Development and psychometric evaluation of the pediatric anesthesia emergence delirium scale. Anesthesiology. 2004 May;100(5):1138-45. doi: 10.1097/00000542-200405000-00015.
PMID: 15114210BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
ren zhou, Doctor
shanghai Ninth People Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 21, 2019
First Posted
October 23, 2019
Study Start
December 30, 2019
Primary Completion
December 30, 2021
Study Completion
December 30, 2021
Last Updated
October 25, 2019
Record last verified: 2019-10
Data Sharing
- IPD Sharing
- Will not share